RTsafe

RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy, has signed an exclusive agreement for Oncology Systems Limited (OSL) to distribute its products and services in the UK and Ireland. OSL science and innovation lead Rob Julian said: “OSL is delighted to partner with RTsafe, whose fully customisable anthropomorphic phantoms […]

Provider of quality assurance products and services in stereotactic radiosurgery RTsafe has partnered with ZAP Surgical, developer of the ZAP-X Gyroscopic Radiosurgery platform, to promote advances in cranial radiosurgery. RTsafe’s dosimetry phantom based on true-to-life human anatomy will be integrated into ZAP Surgical’s existing and future installations. RTsafe’s phantom developed specifically for use with the […]

NSH CyberKnife Cancer Center at the Neuro Spinal Hospital in Dubai has conducted its first simulated therapy for multiple brain cavernomas using PseudoPatient, RTsafe’s patient-specific quality assurance process. This represents the first application of PseudoPatient in the Gulf region. The hospital is said to be the first in the UAE to use the CyberKnife system […]

Radiosurgery departments aiming to achieve International Stereotactic Radiosurgery Society (ISRS) certification can now streamline their preparation process with the help of RTsafe. As a provider of end-to-end stereotactic radiosurgery products and services, RTsafe has launched a dedicated consulting service to help applicants achieve the quality assurance and patient safety requirements of ISRS. The certification service […]

Spain’s Fundación Instituto Valenciano de Oncología (IVO) has conducted its first simulated therapy for brain metastases using RTsafe’s PseudoPatient. This patient-specific quality assurance process comprises an anatomically faithful model of each patient’s head aligned to dosimetric evaluation services. The technology enables medical physicists and clinicians to verify the entire treatment process before the patient is […]